[{"Assets_0_Q3_USD":123169000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-70470000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":4865000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":6652000.0,"StockholdersEquity_0_Q3_USD":103473000.0,"Ticker":"RIGL","CIK":"1034842","name":"RIGEL PHARMACEUTICALS INC","OfficialName":"Rigel Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"488447519.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]